Feng Xiaojing, Yang Yanyi, Xie Huiqi, Zhuang Siqi, Fang Yiyuan, Dai Yufeng, Jiang Ping, Chen Hongzhi, Tang Haoneng, Tang Lingli
Department of Laboratory Medicine, The Second Xiangya Hospital, Central South University, Changsha, China.
Health Management Center of the Second Xiangya Hospital, Central South University, Changsha, China.
Front Nutr. 2022 Apr 18;9:773220. doi: 10.3389/fnut.2022.773220. eCollection 2022.
Serum uric acid (UA) not only affects the development of obesity but also alters the metabolic status in obese subjects; thus we investigated the relationship between serum UA and the overweight/obese metabolic phenotypes.
The demographic, biochemical, and hematological data were collected for 12,876 patients undergoing routine physical examination, and 6,912 participants were enrolled in our study. Participants were classified into four obesity metabolic phenotypes according to their BMI and the presence of metabolic syndrome: metabolically healthy overweight/obese (MHOO), metabolically healthy and normal weighted (MHNW), metabolically abnormal and overweight/obese (MAOO), and metabolically abnormal but normal weighted (MANW). Univariate and multivariate logistic regression analysis, stratified analysis, and also interaction analysis were conducted to analyze the relationship between serum UA and obesity metabolic phenotypes.
Multivariable logistic regression analysis showed that hyperuricemia was positively associated with MHOO, MANW, and MAOO phenotypes relative to MHNW. After adjusting for the confounding factors, the odds ratios (OR) for individuals with hyperuricemia to be MHOO, MANW, and MAOO phenotypes were 1.86 (1.42-2.45), 2.30 (1.44-3.66), and 3.15 (2.34-4.24), respectively. The ORs for having MHOO, MANW, and MAOO increased 6% [OR: 1.06 (1.05-1.07), < 0.0001], 5% [OR: 1.05 (1.03-1.07), < 0.0001], and 11% [OR: 1.11 (1.10-1.13), < 0.0001] for each 10 unit (μmol/L) of increase in serum UA level. Stratification analysis as well as an interaction test showed that sex and age did not interfere with the association of hyperuricemia with each metabolic phenotype. In terms of the components of the metabolic syndrome, after adjusting for other confounding factors including all of the metabolic indicators except itself, hyperuricemia was positively associated with increased BMI [OR: 1.66 (1.32-2.09), < 0.0001], hypertriglyceridemia [OR: 1.56 (1.21-2.02), = 0.0006], and hypertension [OR: 1.22 (1.03-1.46), = 0.0233], while it had no significant association with hyperglycemia and low HDL-C (all > 0.05).
In our study, we discovered that hyperuricemia was positively associated with MHOO, MANW, and MAOO phenotypes, and this relationship was independent of sex and age.
血清尿酸(UA)不仅影响肥胖的发展,还会改变肥胖受试者的代谢状态;因此,我们研究了血清UA与超重/肥胖代谢表型之间的关系。
收集了12876例接受常规体检患者的人口统计学、生化和血液学数据,其中6912名参与者纳入我们的研究。根据参与者的体重指数(BMI)和代谢综合征的存在情况,将其分为四种肥胖代谢表型:代谢健康的超重/肥胖(MHOO)、代谢健康且体重正常(MHNW)、代谢异常的超重/肥胖(MAOO)和代谢异常但体重正常(MANW)。进行单因素和多因素逻辑回归分析、分层分析以及交互分析,以分析血清UA与肥胖代谢表型之间的关系。
多因素逻辑回归分析显示,相对于MHNW,高尿酸血症与MHOO、MANW和MAOO表型呈正相关。在调整混杂因素后,高尿酸血症个体为MHOO、MANW和MAOO表型的优势比(OR)分别为1.86(1.42 - 2.45)、2.30(1.44 - 3.66)和3.15(2.34 - 4.24)。血清UA水平每升高10个单位(μmol/L),MHOO、MANW和MAOO的OR分别增加6% [OR:1.06(1.05 - 1.07),<0.0001]、5% [OR:1.05(1.03 -